26-Desglucoavenacoside A



Compound IDCDAMM02239
Common name26-Desglucoavenacoside A
IUPAC name2-[4-hydroxy-2-(hydroxymethyl)-6-[5\'-(hydroxymethyl)-5\',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2\'-oxolane]-16-yl]oxy-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
Molecular formulaC45H72O18

Experimental data

Retention time7.5
Adduct[M+H]+
Actual mz901.479
Theoretical mz901.479
Error0.64
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3454

Identifiers and class information

Inchi keyXUUBSPXZCBAWET-UHFFFAOYNA-N
SmilesOCC1OC(OC2C(O)C(OC3OC(C)C(O)C(O)C3O)C(OC2OC4CC5=CCC6C(CCC7(C)C6CC8OC9(OC(C)(CO)CC9)C(C)C87)C5(C)CC4)CO)C(O)C(O)C1O
SuperclassLipids and lipid-like molecules
ClassSteroids and steroid derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)14
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)19
Number of reactive functional groups (#rtvFG)4
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)901.053
Computed dipole moment(dipole)4.049
Total solvent accessible surface area (SASA)1134.34
Hydrophobic component of SASA (FOSA)768.868
Hydrophilic component of SASA (FISA)351.946
Pie component of the SASA (PISA)13.522
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2431.9
Number of hydrogen bond donors (donorHB)10
Number of hydrogen bond acceptors (accptHB)28.7
Free energy of solvation of dipole (dip^2/V)0.0067406
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0800092
Globularity descriptor (glob)0.770999
Predicted polarizability in cubic angstroms (QPpolrz)79.1
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.129
Predicted octanol/gas partition coefficient (QPlogPoct)57.556
Predicted water/gas partition coefficient (QPlogPw)43.659
Predicted octanol/water partition coefficient (QPlogPo/w)-0.686
Predicted aqueous solubility (QPlogS)-3.574
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.557
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.302
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4.554
Predicted brain/blood partition coefficient (QPlogBB)-4.529
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1.457
Predicted skin permeability, log Kp (QPlogKp)-6.134
PM3 calculated ionization potential (IP(ev))9.649
PM3 calculated electron affinity (EA(eV))-0.888
Number of likely metabolic reactions (#metab)12
Prediction of binding to human serum albumin (QPlogKhsa)-1.184
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)0
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)254.428
Number of nitrogen and oxygen atoms (#NandO)18
Number of violations of Lipinski’s rule of five (RuleOfFive)3
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q15125EBPAnti-estrogen binding site (AEBS)T25317SEA
P31213SRD5A2Steroid 5-alpha-reductase 2T71390SEA
Q9UHC9NPC1L1Niemann-Pick C1-like protein 1T33901SEA
Q13133NR1H3LXR-alphaT52297SEA
P11413G6PDGlucose-6-phosphate 1-dehydrogenaseT63484SEA
P05093CYP17A1Cytochrome P450 17A1T89041SEA
P40763STAT3Signal transducer and activator of transcription 3T29130SwissTargetPrediction
P60568IL2Interleukin-2T61698SwissTargetPrediction and SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
Q99417MYCBPMYCBP messenger RNAT37298SEA
O15439ABCC4Multidrug resistance protein 4T39919SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T25317DI0366Rheumatoid arthritis[ICD-11: FA20]Q15125EBP
T71390DI0348Prostate hyperplasia[ICD-11: GA90]P31213SRD5A2
T33901DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]Q9UHC9NPC1L1
T52297DI0117Depression[ICD-11: 6A70-6A7Z]Q13133NR1H3
T63484DI0086Chronic obstructive pulmonary disease[ICD-11: CA22]P11413G6PD
T89041DI0346Prostate cancer[ICD-11: 2C82]P05093CYP17A1
T29130DI0351Psoriasis[ICD-11: EA90]P40763STAT3
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T37298DI0235Liver cancer[ICD-11: 2C12]Q99417MYCBP

Copyright © 2025